A carregar...
Optimising IBD patient selection for de-escalation of anti-TNF therapy to immunomodulator maintenance
OBJECTIVE: Inflammatory bowel disease (IBD) is increasingly managed with the use of biologic therapies. National guidelines (National Institute for Health and Care Excellence (NICE)) suggest considering cessation after 1 year of therapy but lack detailed criteria for this. We aimed to describe clini...
Na minha lista:
| Publicado no: | Frontline Gastroenterol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6914296/ https://ncbi.nlm.nih.gov/pubmed/31885835 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/flgastro-2018-101135 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|